Evidence map›Paper›PMID 35071839›Full record

ReviewBrain circulation

Protection of multiple ischemic organs by controlled reperfusion.

Jin Ma, Ming Li, Mengke Zhang, Miuwen Jiang, Yuan Gao, Ruchi Mangal, Yuchuan Ding, Zhichen Yin, Xunming Ji

Open access · diamondAbstract readReview
In one paragraph

Review in Brain circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The temporal dynamic of bradykinin type 2 receptor effects reveals its neuroprotective role in the chronic phase of cerebral and retinal ischemic injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Article
  5. Article
  6. Review
  7. Prediction of early neurological deterioration in acute ischemic stroke patients treated with intravenous thrombolysis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jin MaDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Ming LiDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Mengke ZhangDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Miuwen JiangSchool of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing, China.
Yuan GaoSchool of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing, China.
Ruchi MangalDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Yuchuan DingChinaAmerica Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Zhichen YinChinaAmerica Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
Xunming JiDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeihang University · CNWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reperfusion injury (RI) is a harmful complication that takes place during recanalization treatment of ischemic organs. Currently, there are no efficacious treatments for protecting the organs against RI. Therefore, it is necessary to discover new strategies to prevent RI. As a novel intervention technique, controlled reperfusion has promising effects on protecting multiple organs from RI, and it is done by adjusting physical parameters of blood flow or chemical compositions of the reperfusion liquid. In this brief review, the status of various controlled reperfusion methods is presented, as well as their application in the protection of ischemic organs.

Indexed as

Controlled reperfusionorgan protectionreperfusion injury

Identifiers

PMID35071839
PMCPMC8757498
OpenAlexW4205917045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.